JP2009256392A5 - - Google Patents

Download PDF

Info

Publication number
JP2009256392A5
JP2009256392A5 JP2009187809A JP2009187809A JP2009256392A5 JP 2009256392 A5 JP2009256392 A5 JP 2009256392A5 JP 2009187809 A JP2009187809 A JP 2009187809A JP 2009187809 A JP2009187809 A JP 2009187809A JP 2009256392 A5 JP2009256392 A5 JP 2009256392A5
Authority
JP
Japan
Prior art keywords
riera
dunaliella
donna
genus
crude
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2009187809A
Other languages
English (en)
Japanese (ja)
Other versions
JP5356946B2 (ja
JP2009256392A (ja
Filing date
Publication date
Priority claimed from US10/668,601 external-priority patent/US7264813B2/en
Application filed filed Critical
Publication of JP2009256392A publication Critical patent/JP2009256392A/ja
Publication of JP2009256392A5 publication Critical patent/JP2009256392A5/ja
Application granted granted Critical
Publication of JP5356946B2 publication Critical patent/JP5356946B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2009187809A 2003-09-24 2009-08-13 ドナリエラ属（Ｄｕｎａｌｉｅｌｌａ）の粉末の治療的使用 Expired - Lifetime JP5356946B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/668,601 US7264813B2 (en) 2003-09-24 2003-09-24 Therapeutic uses of Dunaliella powder
US10/668601 2003-09-24

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2004212054A Division JP5020463B2 (ja) 2003-09-24 2004-07-20 ドナリエラ属（Ｄｕｎａｌｉｅｌｌａ）の粉末の治療的使用

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2013126599A Division JP2013177457A (ja) 2003-09-24 2013-06-17 ドナリエラ属（Ｄｕｎａｌｉｅｌｌａ）の粉末の治療的使用

Publications (3)

Publication Number Publication Date
JP2009256392A JP2009256392A (ja) 2009-11-05
JP2009256392A5 true JP2009256392A5 (https=) 2012-01-19
JP5356946B2 JP5356946B2 (ja) 2013-12-04

Family

ID=34313520

Family Applications (5)

Application Number Title Priority Date Filing Date
JP2004212054A Expired - Fee Related JP5020463B2 (ja) 2003-09-24 2004-07-20 ドナリエラ属（Ｄｕｎａｌｉｅｌｌａ）の粉末の治療的使用
JP2009187809A Expired - Lifetime JP5356946B2 (ja) 2003-09-24 2009-08-13 ドナリエラ属（Ｄｕｎａｌｉｅｌｌａ）の粉末の治療的使用
JP2013126599A Withdrawn JP2013177457A (ja) 2003-09-24 2013-06-17 ドナリエラ属（Ｄｕｎａｌｉｅｌｌａ）の粉末の治療的使用
JP2016104166A Expired - Fee Related JP6321074B2 (ja) 2003-09-24 2016-05-25 ドナリエラ属（Ｄｕｎａｌｉｅｌｌａ）の粉末の治療的使用
JP2017235555A Expired - Lifetime JP6490782B2 (ja) 2003-09-24 2017-12-07 ドナリエラ属（Ｄｕｎａｌｉｅｌｌａ）の粉末の治療的使用

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2004212054A Expired - Fee Related JP5020463B2 (ja) 2003-09-24 2004-07-20 ドナリエラ属（Ｄｕｎａｌｉｅｌｌａ）の粉末の治療的使用

Family Applications After (3)

Application Number Title Priority Date Filing Date
JP2013126599A Withdrawn JP2013177457A (ja) 2003-09-24 2013-06-17 ドナリエラ属（Ｄｕｎａｌｉｅｌｌａ）の粉末の治療的使用
JP2016104166A Expired - Fee Related JP6321074B2 (ja) 2003-09-24 2016-05-25 ドナリエラ属（Ｄｕｎａｌｉｅｌｌａ）の粉末の治療的使用
JP2017235555A Expired - Lifetime JP6490782B2 (ja) 2003-09-24 2017-12-07 ドナリエラ属（Ｄｕｎａｌｉｅｌｌａ）の粉末の治療的使用

Country Status (5)

Country Link
US (3) US7264813B2 (https=)
EP (2) EP1522310B1 (https=)
JP (5) JP5020463B2 (https=)
AT (1) ATE548046T1 (https=)
IL (1) IL162987A (https=)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007210917A (ja) * 2006-02-08 2007-08-23 Kochi Univ 脂肪細胞縮小化剤、医薬品及び飲食品
WO2007109824A1 (en) * 2006-03-24 2007-10-04 Ian Simon Tracton Stable packaged dosage form and process therefor
JP2008222555A (ja) * 2007-03-08 2008-09-25 Nagasakiken Koritsu Daigaku Hojin アディポネクチン受容体発現増加剤
WO2009105048A2 (fr) * 2008-02-19 2009-08-27 Rached Smida Nouvelles applications du hdl reconstitué
JP5443470B2 (ja) * 2008-04-29 2014-03-19 株式会社日健総本社 眼障害の治療方法
US20100303989A1 (en) 2008-10-14 2010-12-02 Solazyme, Inc. Microalgal Flour
JP5733592B2 (ja) * 2008-10-20 2015-06-10 株式会社日健総本社 脂質異常治療薬の副作用防止物質
US8747834B2 (en) 2009-03-03 2014-06-10 Solazyme, Inc. Methods of treating impaired glucose metabolism via administration of algal biomass
WO2011070568A1 (en) 2009-12-10 2011-06-16 Nikken Sohonsha Corporation Method for treating psoriasis
WO2011109559A2 (en) 2010-03-02 2011-09-09 Kyle Terrill Structures and methods of fabricating dual gate devices
US10098371B2 (en) 2013-01-28 2018-10-16 Solazyme Roquette Nutritionals, LLC Microalgal flour
FR3009619B1 (fr) 2013-08-07 2017-12-29 Roquette Freres Compositions de biomasse de microalgues riches en proteines de qualite sensorielle optimisee
GB201718822D0 (en) 2017-11-14 2017-12-27 Univ Greenwich Production of dunaliella
JP6947665B2 (ja) * 2018-03-13 2021-10-13 アイカ工業株式会社 光硬化性粘着樹脂組成物
WO2020202152A1 (en) * 2019-04-01 2020-10-08 Tel Hashomer Medical Research Infrastructure And Services Ltd. Dunaliella alga preparation for prevention and/or treatment of a neurodegenerative disease, a disorder associated with protein misfolding and cognitive decline

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4199895A (en) 1977-05-25 1980-04-29 Yeda Research And Development Co. Ltd. Production of glycerol, carotenes and algae meal
USPP4511P (en) 1978-06-26 1980-03-18 Yeda Research & Development Co. Ltd. Alga strain
DE3729209A1 (de) 1987-09-01 1989-03-09 Boehringer Mannheim Gmbh Verwendung von bezafibrat zur behandlung von diabetes
IL87260A (en) * 1988-02-25 1991-12-15 Tanaka Yoshio Encapsulated food containing dunaliella algae and its production
US5190970A (en) * 1990-10-19 1993-03-02 E. R. Squibb & Sons, Inc. Method for preventing onset of or treating Type II diabetes employing a cholesterol lowering drug alone or in combination with an ace inhibitor
US5219888A (en) 1992-03-31 1993-06-15 American Cyanamid Company Use of retinoids for the treatment of coronary artery disease
DE69327100T2 (de) 1992-06-04 2000-04-13 Betatene Pty. Ltd., Cheltenham Gemisch mit hohem gehalt an cis beta-carotin
US6262109B1 (en) * 1995-12-22 2001-07-17 Henkel Corporation Methods of preventing and/or treating high serum levels of cholesterol and/or lipids
ATE259227T1 (de) 1995-09-18 2004-02-15 Ligand Pharm Inc Behandlung von niddm (nichtinsulinabhängige diabetes mellitus) mit rxr agonisten
US6028052A (en) * 1995-09-18 2000-02-22 Ligand Pharmaceuticals Incorporated Treating NIDDM with RXR agonists
IL119224A (en) 1996-09-09 2002-11-10 Hadasit Med Res Service Medicament for protection from effects of irradiation
JP3037628B2 (ja) * 1997-03-06 2000-04-24 マイクロアルジェコーポレーション株式会社 健康補助食品用軟カプセルの製法
GB9712866D0 (en) * 1997-06-18 1997-08-20 Smithkline Beecham Plc Novel method of treatment
US6083497A (en) * 1997-11-05 2000-07-04 Geltex Pharmaceuticals, Inc. Method for treating hypercholesterolemia with unsubstituted polydiallylamine polymers
KR20010042373A (ko) 1998-03-30 2001-05-25 린다 에스. 스티븐슨 핵 수용체 활성을 조절하는 방법 및 화합물
JP2000080047A (ja) * 1998-06-30 2000-03-21 Takeda Chem Ind Ltd 医 薬
WO2000000195A1 (en) 1998-06-30 2000-01-06 Takeda Chemical Industries, Ltd. Pharmaceutical composition for the treatment of diabetes
IL126447A (en) * 1998-10-04 2004-09-27 Vascular Biogenics Ltd An immune preparation that confers tolerance in oral administration and its use in the prevention and / or treatment of atherosclerosis
JP2002533410A (ja) * 1998-12-23 2002-10-08 ジー．ディー．サール エルエルシー 心臓血管に適用するためのコレステリルエステル転送タンパク質阻害剤およびフィブリン酸誘導体の組み合わせ
US6914073B2 (en) * 1999-03-18 2005-07-05 Bristol Myers Squibb Company Vitamin formulation for cardiovascular health
FR2795961B1 (fr) * 1999-07-09 2004-05-28 Ethypharm Lab Prod Ethiques Composition pharmaceutique contenant du fenofibrate micronise, un tensioactif et un derive cellulosique liant et procede de preparation
AU7586600A (en) 1999-09-14 2001-04-17 Ligand Pharmaceuticals Incorporated Rxr modulators with improved pharmacologic profile
US6680387B2 (en) * 2000-04-24 2004-01-20 Aryx Therapeutics Materials and methods for the treatment of diabetes, hyperlipidemia, hypercholesterolemia, and atherosclerosis
GB0019226D0 (en) * 2000-08-04 2000-09-27 Smithkline Beecham Plc Novel pharmaceutical
AU2002333655A1 (en) 2001-09-25 2003-04-07 Smithkline Beecham Corporation Bicyclic heterocycles as rxr ligands
IN189624B (https=) * 2001-10-23 2003-03-29 Ajanta Pharma Ltd
JP3978582B2 (ja) * 2001-12-19 2007-09-19 株式会社日健総本社 カロチノイドの製造方法
US20030212138A1 (en) * 2002-01-14 2003-11-13 Pharmacia Corporation Combinations of peroxisome proliferator-activated receptor-alpha agonists and cyclooxygenase-2 selective inhibitors and therapeutic uses therefor

Similar Documents

Publication Publication Date Title
JP5356946B2 (ja) ドナリエラ属（Ｄｕｎａｌｉｅｌｌａ）の粉末の治療的使用
JP2009256392A5 (https=)
CN1993119B (zh) 含他汀类药物和ω-3脂肪酸的组合物
JP2755559B2 (ja) 前脂肪細胞の分化を刺激する組成物と方法、およびこれに関連する治療処置方法
AU2001286576B2 (en) Composition and method for treatment of hypertriglyceridemia
EA011637B1 (ru) Лечение с использованием омега-3 жирных кислот и агониста и/или антагониста ppar и их комбинированный продукт
AU2001286576A1 (en) Composition and method for treatment of hypertriglyceridemia
JP2008521863A (ja) Ｈｉｖ感染患者における抗レトロウイルス治療がひき起こす高コレステロール血症の治療のためのオメガ−３脂肪酸の利用
JP5810166B2 (ja) 糖尿病性心血管合併症の予防・治療剤
AU2015279905A1 (en) Treatment of severe hypertriglyceridemia
US6890941B1 (en) Compositions containing HMG Co-A reductase inhibitors and policosanol
Black Atorvastatin: a step ahead for HMG-CoA reductase inhibitors
HK1071845B (en) Therapeutic uses of dunaliella powder
JP2020503388A (ja) 悪液質を予防及び／又は処置するためのオメガ−３脂肪酸組成物
WO1993009773A1 (fr) Composition servant a prevenir ou a traiter la dysmenorrhee et aliment ayant une fonction de prevention de la dysmenorrhee